Robert Plenge
Vermögen: 2 Mio $ am 31.08.2026
Vermögen: 2 Mio $ am 31.08.2026
Dr. Robert M.
Plenge is an Independent Director at BioMarin Pharmaceutical, Inc. and a Chief Research Officer, EVP & Head-Research at Bristol Myers Squibb Co. He is on the Board of Directors at BioMarin Pharmaceutical, Inc. and PhRMA Foundation.
Dr. Plenge was previously employed as a VP-Translational Development & Research by Celgene Corp., a Vice President & Head-Translational Medicine by Merck & Co., Inc., an Associate Member-Broad Institute by The Brigham & Women's Hospital, Inc., and an Associate Member by The Broad Institute, Inc. He also served on the board at Translate Bio, Inc. He received his undergraduate degree from the University of California San Diego and a doctorate degree from Case Western Reserve University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.03.2026 | 24.754 ( 0 % ) | 2 Mio $ | 31.08.2026 | |
| 10.09.2026 | 6.140 ( 0 % ) | 400 512 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2019 |
| BIOMARIN PHARMACEUTICAL INC. | Direktor/Vorstandsmitglied | 10.09.2026 |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Direktor/Vorstandsmitglied | - |
Alltrna
Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSLATE BIO, INC. | Direktor/Vorstandsmitglied | 14.09.2021 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.05.2017 |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | 01.01.2013 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 01.01.2013 |
| CELGENE | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Translate Bio, Inc.
Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Alltrna
Alltrna Pharmaceuticals: MajorHealth Technology Develops tRNA-based medicines for genetic disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen